SCHEMBL7219340

SCHEMBL7219340

O=[N+]([O-])c1c(Cc2ccccc2)cccc1Oc1cccc(Cc2ccccc2)c1[N+](=O)[O-]

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CYP19A1 P11511 1/20 0.40
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40
ALDH1A1 P00352 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
HRH1 P35367 3/20 0.39
DRD2 P14416 2/20 0.39
DRD1 P21728 2/20 0.39
DRD4 P21917 1/20 0.39
DRD5 P21918 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.38
TP53 P04637 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
TSHR P16473 1/20 0.38
NPC1 O15118 1/20 0.38
RECQL P46063 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11130387 0.86 NPC1 (0.39) HPGDSMN1; SMN2ALDH1A1TDP1HRH1
SCHEMBL6513679 0.85 HPGD (0.42) HPGDSMN1; SMN2CYP19A1CYP11B1CYP11B2
SCHEMBL6513683 0.85 HPGD (0.42) HPGDSMN1; SMN2CYP19A1CYP11B1CYP11B2
SCHEMBL27634125 0.80 ALDH1A1 (0.60) HPGDSMN1; SMN2ALDH1A1TDP1L3MBTL1
SCHEMBL27446682 0.80 TSHR (0.53) HPGDSMN1; SMN2ALDH1A1TDP1TSHR
Fluoride SCHEMBL27378143 0.79 TSHR (0.51) HPGDSMN1; SMN2ALDH1A1TDP1TSHR
SCHEMBL3476385 0.79 HTR2A (0.41) HPGDSMN1; SMN2ALDH1A1TDP1LMNA
SCHEMBL16241188 0.79 GPR35 (0.51) HPGDALDH1A1TDP1CYP3A4
SCHEMBL7628294 0.77 ERN1 (0.42) SMN1; SMN2ALDH1A1TDP1TSHRNPC1
SCHEMBL7628291 0.76 TSHR (0.44) HPGDALDH1A1TDP1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6596734-B1 Method for stimulating, regulating and modulating metabolism of fats in adipose tissue in mammals, comprising administering to a mammal an effective amount of a beta 3- adrenoreceptor agonist MOLECULAR DESIGN INTERNATIONAL, INC. 2003-07-22 US disclosed